title: ICS 205-930 reduces 5-methoxytryptamine-induced short-circuit current in stripped pig jejunum.
abstract: The effect of ICS 205-930 on serotonin (5-hydroxytryptamine, 5-HT) and 5-methoxytryptamine (5-MeOT) induced short-circuit current (SCC) was studied in muscle-stripped pig jejunum in vitro. The selective 5-HT4 receptor agonist 5-MeOT and 5-HT both induced a concentration-dependent increase in SCC. The maximal efficacy of 5-HT was twice that of 5-MeOT. ICS 205-930 (Tropisetron) induced a small increase in SCC. Furthermore, ICS 205-930 reduced the 5-MeOT but not the 5-HT induced increase in SCC, except at the 100 microM ICS 205-930 concentration. Pretreatment with bumetanide reduced 5-HT, 5-MeOT, and ICS 205-930 induced peak increases in SCC by 64, 75, and 58%, respectively. Pretreatment with atropine reduced 5-HT, 5-MeOT, and ICS 205-930 induced peak increases in SCC by 38, 75, and 58%, respectively. Pretreatment with hexamethonium reduced 5-HT, 5-MeOT, and ICS 205-930 induced peak increases in SCC by 33, 50, and 36%, respectively. Pretreatment with tetrodotoxin reduced the peak increase in SCC elicited by 5-MeOT and ICS 205-930 by 41 and 50%, respectively. This study demonstrates involvement of a ICS 205-930, hexamethonium, atropine, bumetanide, and tetrodotoxin sensitive receptor in 5-MeOT induced SCC in muscle-stripped pig jejunum in vitro. These data suggest involvement of a neuronal 5-HT4 receptor subtype and acetylcholine in 5-HT elicited SCC and chloride secretion in the pig jejunum.
authors.affiliation: Department of Anatomy and Physiology, Royal Veterinary and Agricultural University, Frederiksberg C, Denmark.
authors.forename: M B
authors.initials: MB
authors.lastname: Hansen
mesh_terms: D008735:5-Methoxytryptamine / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002034:Bumetanide / Q000494:pharmacology; D004347:Drug Interactions; D004594:Electrophysiology; D005260:Female; D018738:Hexamethonium; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007583:Jejunum / Q000187:drug effects* / Q000502:physiology* / Q000648:ultrastructure; D007700:Kinetics; D011985:Receptors, Serotonin / Q000145:classification / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology*; D013552:Swine; D013779:Tetrodotoxin / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D000077526:Tropisetron
chemical_list: D006584:Hexamethonium Compounds; D007211:Indoles; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D002034:Bumetanide; D012701:Serotonin; D018738:Hexamethonium; D008735:5-Methoxytryptamine; D013779:Tetrodotoxin; D000077526:Tropisetron; D001285:Atropine; D013806:Theophylline